# Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI

Study · id `cardio:ct-nct03045562` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03045562](<https://clinicaltrials.gov/study/NCT03045562>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03045562

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 536 participants.

## Technical summary

Registry record NCT03045562. Randomized; quadruple masking; primary purpose treatment. Start 2017-01-20 (actual); primary completion 2018-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 536 participants (planned count; ClinicalTrials.gov record NCT03045562, source copy `cardio:ctgov-nct03045562-2017-02-07`, retrieved 2026-10-26)
- Started: 2017-01-20 (actual) (ClinicalTrials.gov record NCT03045562, source copy `cardio:ctgov-nct03045562-2017-02-07`, retrieved 2026-10-26)
- Primary completion: 2018-12-31 (anticipated) (ClinicalTrials.gov record NCT03045562, source copy `cardio:ctgov-nct03045562-2017-02-07`, retrieved 2026-10-26)
- Completion: 2018-12-31 (anticipated) (ClinicalTrials.gov record NCT03045562, source copy `cardio:ctgov-nct03045562-2017-02-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03045562, source copy `cardio:ctgov-nct03045562-2017-02-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03045562-2017-02-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI
- Acronym: SISTEMI
- Condition: STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug): Normal saline
- Intervention (Drug): Salvianolate injection
- Lead sponsor: Green Valley Group of China
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

## Provenance

Content hash: e36acff71acd1e09530d561f6d939072f8b3987e21226bea79b4a71f0f70e5c6
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
